在美国妇女中使用Levonorgestrel释放子宫内系统的模式
Paul G Yeh1, Allen Haas2, Charlotte C Sun3
1Department of Management, Policy, and Community Health, University of Texas Health Science Center at Houston School of Public Health, Houston, Texas.
Cancer prevention research (Philadelphia, Pa.)
|February 11, 2025
概括
该研究发现,6.9%的美国女性使用levonorgestrel释放子宫内系统 (LNG-IUS). 在西班牙裔妇女和糖尿病患者中,使用率较低,这表明在这些群体中可能预防子宫内膜癌.
科学领域:
- 生殖健康 生殖健康
- 妇科瘤学 妇科瘤学
- 公共卫生 公共卫生
背景情况:
- levonorgestrel释放子宫内系统 (LNG-IUS) 是FDA批准的避孕和严重的月经出血.
- LNG-IUS有效治疗子宫内膜增生,这是子宫内膜癌的前体.
- 目前在美国使用LNG-IUS的模式没有得到充分的记录.
研究的目的:
- 分析美国生育年龄妇女中LNG-IUS使用的流行率和预测因素.
- 确定与LNG-IUS利用相关的人口和健康因素.
- 为潜在的子宫内膜癌初级预防策略提供信息.
主要方法:
- 来自2017-2019年国家家庭增长调查 (年龄在18-50岁的女性) 的加权数据的分析.
- 按种族/种族和子宫内膜癌风险因素分类的分层总结统计.
- 双变的罗-斯科特奇方测试和多变量后勤回归以确定LNG-IUS使用的预测因素.
主要成果:
- 整体LNG-IUS使用率为6.9% (95%CI,5.9%-8.1%).
- 在西班牙裔妇女,受教育程度较低的妇女,未婚妇女,没有保险的妇女和糖尿病妇女中观察到更低的使用率.
- 在拥有大学学位的女性,未婚妇女和保险妇女中观察到更高的使用率.
结论:
- 美国LNG-IUS的使用与特定的人口和健康特征有关.
- 某些群体,包括西班牙裔妇女,受教育程度较低的妇女,未婚妇女,没有保险的妇女和糖尿病妇女,使用LNG-IUS的几率较低.
- 需要进一步的研究来证实LNG-IUS在子宫内膜癌预防中的有效性,并探索其在高风险人群的初级预防策略中的作用.
更多相关视频
05:46Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
9.7K
03:30Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
Published on: October 25, 2024
1.3K
相关概念视频
01:22Birth Control Methods
167
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
167
01:30Hormonal Control of the Ovarian Cycle
391
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
391
01:22Hormonal Regulation of the Menstrual Cycle
269
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
269
01:27Ovarian Cycle
940
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
940
01:24Disorders of the Female Reproductive System
311
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
311
01:19The Menstrual Cycle
664
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
664